Peptide questions · Methylene Blue
How long does Methylene Blue take to work?
Reviewed Evidence: EmergingPublished by PepVault
Methylene Blue’s onset is about an hour (one-dose fMRI trial), its peak effect comes at not established, and its typical duration is no long-term trials of the low-dose use, by the library’s timeline (backed by preliminary research).
The timeline’s basis: The ProvayBlue FDA label (DailyMed, Jun 2025); one small single-dose fMRI RCT; a large negative phase 3 trial of a related compound; the ITP; an oral PK study.
Methylene Blue week by week
The library places three of its research notes on Methylene Blue on the days they cover, from day 1 to day 30: 2 on clinical data and 1 on randomized trials.
Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.
| When | The note | Evidence |
|---|---|---|
| Days 1–3 (week 1) | Blue urine is the expected sign | Clinical data |
| Days 1–14 (weeks 1–2) | A sharper hour, in one small trial | Randomized trial |
| Days 1–30 (weeks 1–5) | The one combination to know | Clinical data |

The Methylene Blue timeline’s milestones
The library’s timeline for Methylene Blue marks 3 points from day 1 to week 65, backed by preliminary research overall.
- Day 1: An hour after a single 280 mg dose, memory retrieval was 7% better than placebo in 26 adults
- Day 1: Urine turns blue-green as the dye is cleared; the label's half-life is about 24 hours
- Week 65: In 891 people with Alzheimer disease, the related LMTM showed no benefit over 15 months
The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.
Why Methylene Blue takes that long
Methylene Blue’s half-life is about 24 hours, so one dose is about 96.9% cleared after 5 days.
On its schedule (Daily) the doses overlap, and the level of Methylene Blue keeps climbing for about 4–5 days before it levels off, so the first 4–5 days run below the level the later weeks hold.
Methylene Blue against other longevity compounds
The library holds an onset-and-peak timeline for 38 longevity compounds, Methylene Blue among them; none of the others shares its onset of about an hour (one-dose fMRI trial).
| Compound | Onset | Peak effect |
|---|---|---|
| Creatine | 1 week with loading, 3–4 weeks without (muscle stores full) | Months of training (lean mass and strength) |
| Magnesium | 1–4 weeks (sleep, in the trials) | 12 weeks (blood pressure) |
| Vitamin D3 + K2 | About 3 months for blood vitamin D to rise to a new level | Not felt; measured by a 25(OH)D blood test |
| Omega-3 (EPA/DHA) | Weeks (triglycerides; membranes fill over weeks) | Months |
| Taurine | A single dose (endurance); weeks (blood pressure) | 12 weeks (blood pressure, in the trial) |
| Glycine | The first night (sleep, in the trials) | Not established |
| NAC | Hours (blood levels after a dose) | Not established for supplement use |
| Low-Dose Naltrexone | Weeks (reported) | Not established |
| Melatonin | The first night | Weeks (insomnia trials) |
| L-Citrulline | Hours (blood arginine); a single pre-workout dose in sports trials | 1 week (blood arginine at steady dosing) |
| Rapamycin | Not felt; the trials measure safety and markers over months | Not established in people |
| Metformin | Days (blood sugar); the stomach adjusts over 1–3 weeks | Weeks to months (HbA1c) |
| Berberine | 1 week (blood sugar, in one trial) | 3 months (HbA1c) |
| Nicotinamide Riboside | Hours (blood NAD+ after a dose); 2 weeks to a steady higher level | 2 weeks (blood NAD+) |
| Resveratrol | Not established | Not established |
| Spermidine | Not felt; trials measured months | Not established |
| Vitamin B12 | Days to weeks when correcting a deficiency | 3–4 months (blood levels, in the oral-vs-injection trials) |
| Calcium Alpha-Ketoglutarate | Not established | Not established |
| Sulforaphane | Days (pollutant clearance rose quickly) | 12 weeks (in the trials) |
| DHEA | Weeks (blood DHEA-S) | Not established |
| CoQ10 | 4–12 weeks (statin muscle aches, in trials) | Months to years (heart outcomes) |
| PQQ | 8–12 weeks (cognition, in trials) | 12 weeks |
| Urolithin A | 4 weeks (blood markers) | 2–4 months (muscle measures, in trials) |
| Methylene Blue | About an hour (one-dose fMRI trial) | Not established |
| Astaxanthin | 8–12 weeks (skin, exercise) | 12+ weeks |
| Vitamin C | Weeks (blood pressure) | 8 weeks (blood pressure trials) |
| Vitamin A | Not applicable (an essential vitamin) | Not applicable |
| Thiamine (Benfotiamine) | Weeks (nerve symptoms) | Not established |
| TMG (Betaine) | 6 weeks (homocysteine) | Not established |
| Fucoidan | Not established | 12 weeks (older-adult trial) |
| Quercetin | Days (senolytic pulse); weeks (blood pressure) | Not established |
| Fisetin | Not established | Not established |
| Curcumin | 2–4 weeks (joint pain, reported) | 8–12 weeks (knee trials) |
| EGCG | Not established for benefits | Not established |
| Ginger | Hours to days (nausea) | Days |
| Ashwagandha | 2–4 weeks (reported) | 8 weeks or more (sleep trials) |
| Cordyceps | Acute (single-dose studies) to 12 weeks | 12 weeks (older-adult trial) |
| Hyaluronic Acid (oral) | 8 weeks (skin, in the trial) | 12 weeks |
Questions people ask
How long does Methylene Blue take to work?
Methylene Blue’s onset is about an hour (one-dose fMRI trial), its peak effect comes at not established, and its typical duration is no long-term trials of the low-dose use, by the library’s timeline (backed by preliminary research).
When does Methylene Blue reach its peak effect?
By the library’s timeline, Methylene Blue’s peak effect comes at not established, backed by preliminary research.
How long is Methylene Blue usually run?
The library’s timeline gives Methylene Blue’s typical duration as no long-term trials of the low-dose use; its cycle note says: The trials gave single doses (fMRI study) or 15 months of a related compound (LMTM, Alzheimer disease).
What does the library say about the first days on Methylene Blue?
Its first note on Methylene Blue, for days 1–3 (week 1), is “Blue urine is the expected sign”, resting on clinical data.